Robert Dee Etherington - 29 Jun 2023 Form 4 Insider Report for Clene Inc. (CLNN)

Role
Chief Executive Officer, Director
Signature
/s/ Jerry Miraglia POA
Issuer symbol
CLNN
Transactions as of
29 Jun 2023
Transactions value $
$0
Form type
4
Filing time
03 Jul 2023, 13:49:59 UTC
Previous filing
27 Jun 2023
Next filing
10 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLNN Stock Options (Right to buy) Award $0 +900,000 $0 900,000 29 Jun 2023 Common Stock 900,000 $0.9 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 29, 2023 as an option for 900,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.90 per share. The options vest with respect to the first 25% of such shares on June 29, 2024 and then in 36 equal installments of the balance of the shares of Common Stock on the last day of each calendar month beginning July 29, 2024 until such shares are fully vested. If Clene Inc. has an NDA accepted by the FDA, 50% of the option shares shall vest on that date. If the FDA approves the accepted NDA, the then remaining unvested option shares shall vest on that date.